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Abstract Turner syndrome (TS) is a congenital disease caused by absence or structural 
abnormalities of sex chromosomes resulting in gonadal dysgenesis. Spontaneous 
pregnancies occur in 2–8% of patients, especially with mosaic kariotypes, how-
ever they are associated with increased risk of poor outcome both for mother 
and fetus. We report a 4-day-old male infant delivered by women with mosaic TS 
who was admitted to the pediatric intensive care unit and presented with severe 
panhypopituitarism as the early manifestation of pituitary stalk interruption 
syndrome (PSIS). To the best of our knowledge this is the first report of severe 
panhypopituitarism in a newborn borne by women with TS. 
INTRODUCTION
Turner syndrome (TS) is a congenital disease 
caused by numerical or structural aberrations of 
sex chromosomes occurring in 1:2 000 to 1:2 500 
liveborn females. It is usually characterized by 
short stature and gonadal dysgenesis resulting 
in delayed puberty, primary amenorrhea and 
infertility (Lacka 2005; Abir et al. 2001). Spon-
taneous puberty is observed in 15–30% of girls 
with TS and 2–20% of patients experience men-
arche without hormonal substitution. Sponta-
neous conceptions occur in 2–8% (Abir et al. 
2001; El-Mansoury et al. 2007; Hagman et al. 
2011; Birkebaek et al. 2002; Hewitt et al. 2013). 
Pregnancies in TS women are associated with 
increased risk of poor outcome both for mother 
and fetus. Pregnancy-related complications in TS 
patients include preeclampsia, aortic dissection 
or rupture and spontaneous abortion. In chil-
dren delivered by mothers with TS increased rate 
of prematurity, intrauterine growth restriction 
and chromosomal aberrations, especially TS and 
Down syndrome was observed (Abir et al. 2001; 
Hewitt et al. 2013). Congenital anomalies includ-
ing ambiguous genitalia and hydrocephalus have 
been also reported (Birkebaek et al. 2002). To the 
best of our knowledge this is the first report of 
severe panhypopituitarism in a patient borne by 
women with TS.
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Severe panhypopituitarism in a newborn
CASE PRESENTATION
A 4-day-old male infant was admitted to the pediatric 
intensive care unit due to hypoglycaemia (2 mmol/L), 
myoclonic seizures and respiratory distress. He was 
delivered by women with TS diagnosed at the age of 
36. She was referred for peripheral blood karyotype 
analysis due to primary infertility, but conceived spon-
taneously in the interterm before obtaining karyotype 
result, which revealed mosaic TS: 45,X/46,XX/47,XXX 
(92%/6%/2%). Her partner’s karyotype was 46,XY. 
The child was born at 36 weeks of gestation, via 
cesarean section due to decreased fetal heart rate vari-
ability in cardiotocography, with birth weight 2 000 g 
and APGAR scores of 7 and 8 at 1 and 5 min, respec-
tively. The patient’s karyotype was 46,XY. Physical 
examination revealed jaundice and left-sided crypt-
orchidism. The child was diagnosed with early-onset 
sepsis (white blood cells: 20 000/μL, C-reactive pro-
tein: 21.8 mg/L, interleukin 6: >1000 pg/mL), dis-
seminated intravascular coagulation (platelet count: 
102 000/μL, APTT: 125.9 s, INR: 2.29, fibrinogen level: 
1.15 g/L), prolonged jaundice with elevated hepatic 
enzymes (total bilirubin: 256 μmol/L, direct bilirubin: 
57.4 μmol/L, aspartate transaminase: 205 IU/L, ala-
nine transaminase: 132 IU/L) and diabetes insipidus 
(blood sodium level 147 mmol/L and serum osmolal-
ity 317 mOsm/kg). The child presented with persis-
tent hypoglycaemia (min. 0.56 mmol/L). Hormonal 
analysis disclosed secondary hypothyroidism (TSH: 
0.15 μIU/mL, N: 0.8–9.1 μIU/mL, fT4 6.4 pmol/L, 
N: 10–25 pmol/L), secondary adrenal insufficiency 
(ACTH <5 pg/mL, N: 10–60 pg/mL, blood cortisol: 
2.9 ng/dL N: 50–230 ng/dL) and hypogonadotropic 
hypogonadism (FSH: 1.04 IU/L, N: 1.22–5.19 IU/L, LH: 
2.42 IU/L, N: 4.85–10 IU/L, testosterone <0.1 ng/mL, 
N 0.2–0.49 ng/mL). Growth hormone deficiency was 
confirmed by test of nocturnal GH secretion and in 
stimulation test with arginine (max GH 6.32 ng/mL and 
5.86 ng/mL respectively). Magnetic resonance imaging 
(MRI) of the brain revealed hypoplastic pituitary with 
thin pituitary stalk, lacking normal posterior pituitary 
signal and absence of septum pellucidum (Figures 1 and 
2). The diagnosis of pituitary stalk interruption syn-
drome (PSIS) with early manifestation of severe pan-
hypopityuitarism was set. Replacement therapy with 
hydrocortisone, thyroxine, recombinant human growth 
hormone (rhGH) and desmopressin was implemented. 
DISCUSSION
Spontaneous pregnancies are rarely observed in women 
with TS, especially over 34 years of age (Abir et al. 2001). 
Fertility without use of assisted reproductive technolo-
gies occur mostly in patients with mosaic karyotypes 
(Lacka 2005; Abir et al. 2001). This fact stays in line 
with the current evidence that only 46,XX germ cells in 
ovaries are able to complete meiosis (Modi et al. 2003). 
However, spontaneous pregnancies were reported also 
in simple X monosomic patients (El-Shawarby & Steer 
2007; Mortensen et al. 2010). The most likely reason for 
that is, that the most frequently performed peripheral 
blood karyotype may not reflect chromosomal status of 
the ovarian tissue (Hewitt et al. 2013).
In most of the previously conducted studies preg-
nancies in TS women are regarded as high risk due 
Fig. 1. Sagittal T1-weighted image showing hypoplastic anterior 
pituitary and absence of septum pellucidum.
Fig. 2. Coronal T1-weighted image – thin pituitary stalk and 
absence of septum pellucidum.
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to baseline genetic load including thyroid dysfunc-
tion, congenital heart defects, higher susceptibility to 
obesity, diabetes mellitus and acquired cardiovascular 
diseases such as hypertension (Abir et al. 2001; Hewitt 
et al. 2013). Severe complications including fatal aortic 
dissection or rupture and heart failure have been 
described (Karnis et al. 2003). Nevertheless some of the 
studies do not confirm the increased maternal risk in 
these patients (Hagman et al. 2011).
Most of other authors emphasized, that pregnan-
cies in TS patients are associated with increased rate of 
spontaneous abortion, which is likely caused by high 
prevalence of chromosomal aberrations in fetus, espe-
cially TS and Down syndrome (Abir et al. 2001; Hewitt 
et al. 2013). However, small uterus size and poor endo-
metrial receptivity in TS women are another postulated 
reasons of miscarriages (Hewitt et al. 2013; Bakalov et 
al. 2007). The reported incidence of congenital anoma-
lies in liveborn children of TS women ranges between 
4.5% and 20% (Abir et al. 2001; Hagman et al. 2011, 
Hewitt et al. 2013). 
To our knowledge it is the first report of PSIS mani-
fested dramatically as a panhipopituitarism in a new-
born delivered by women with TS. PSIS is defined as an 
association of hormonal deficiencies and radiological 
findings including thin or absent pituitary stalk, aplastic 
or hypoplastic anterior pituitary and ectopic or absent 
posterior pituitary. It can be associated with other mid-
line defects, as in our patient presented with absence of 
septum pellucidum (Wang et al. 2014). PSIS is usually 
manifested as isolated growth hormone deficiency or 
multiple pituitary hormone deficiency with or without 
diabetes insipidus. The age of clinical manifestation 
ranges from neonates to adults. Our case report stays 
in line with other studies presenting persistent hypo-
glycaemia, prolonged jaundice, cryptorchidism and 
micropenis as typical signs of PSIS in neonates (Pinto 
et al. 1997). In older children short stature is regarded 
as the most common symptom (Ram et al. 2014).
Although in some cases of PSIS genetic etiology 
(mutations of HESX1, LHX4, OTX2, or SOX3) have 
been reported, in over 95% the mechanism of PSIS 
remains unknown (Reynaud et al. 2011; Yang et al. 
2013). Considering the increased frequency of breech 
delivery and cesarean sections in children with PSIS, 
in most patients the role perinatal factors (trauma and 
hypoxia) such as in presented case is suggested (Wang 
et al. 2014).
Clinical manifestation of PSIS ranges in age of first 
symptoms and their severity with especially life-threat-
ening course when occurring as panhypopituitarism 
in newborns. The genetic etiology of PSIS (mutations 
of HESX1, LHX4, OTX2, or SOX3) have been docu-
mented in less than 5% of cases. In most patients the 
mechanism of PSIS remains unknown and as in pre-
sented case requires further investigation. As mater-
nal TS might be an essential risk factor for congenital 
abnormalities, infants borne by women with TS should 
remain under special medical supervision.
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